Nima Shiva
Vice President, Strategic Development
Nima Shiva, M.B.A. has served in the life science industry since 1990 first as a scientist and later as an investor and a serial entrepreneur. In that capacity he has been involved in formation and executive management of a number of life science start-ups including Proteio, Inc., Encode Bio, Inc., and Neurion Pharmaceuticals, Inc. Mr. Shiva is the Managing Director of Convergent Investors, LLC., a seed-stage life science venture capital fund based in Los Angeles.
His prior professional life science experiences include equity research in biotechnology and medical devices at Wedbush Morgan Securities as well as technical and research management positions at UC San Diego and Sequana Therapeutics. Mr. Shiva holds an MBA from the University of Southern California and a BS in Physiology and Neurosciences from UC San Diego.
Using [1,2-13C2]-D-Glucose to track Extracellular Bicarbonate and CO2 Production from Complete Glucose Oxidation
![Using [1,2-13C2]-D-Glucose to track Extracellular Bicarbonate and CO2 Production from Complete Glucose Oxidation](http://64.13.252.16/wp-content/uploads/2009/11/Bicarbonate.png)